DMAA — DRUGS MADE IN AMERICA ACQ CRP: 4/28/2026; CASH: $10.05
什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么
最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR
截至Q2 2026,共 25 家机构在其最新 13F 申报中持有 DMAA(DRUGS MADE IN AMERICA ACQ CRP: 4/28/2026; CASH: $10.05),合计申报市值 $126.04M,对应 12.08M 股。按股数计算较上季度减持 33.7%(-5.97M 股),申报市值环比下降 33.1%。持仓集中度较高:前五大持有人占申报市值的 63.8%,前十大的集中度为 90.6%。
与上一季度相比,4 家新建仓位、2 家加仓、13 家减仓、18 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q2 2026 末的持仓状态,并非实时交易。
DRUGS MADE IN AMERICA ACQ CRP: 4/28/2026; CASH: $10.05(DMAA)的主要机构持有人包括 MIZUHO SECURITIES USA LLC、Karpus Management, Inc.、Polar Asset Management Partners Inc.,按 13F 申报市值在本页 54 家持有人中排名居前。
DMAA 属于Financials板块。
本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。
机构逐季持仓趋势
| 季度 | 持有机构数 | 股数 | 金额 | 环比净变动 |
|---|---|---|---|---|
| Q3 2026 | 12 | 9.76M | $98.64M | +33.2% |
| Q2 2026 | 25 | 12.08M | $126.04M | -33.7% |
| Q1 2026 | 39 | 23.24M | $241.27M | -0.9% |
| Q4 2025 | 40 | 23.33M | $239.23M | +1.8% |
| Q3 2025 | 36 | 21.93M | $225.23M | +1.4% |
| Q2 2025 | 31 | 20.83M | $212.38M | -1.3% |
| Q1 2025 | 22 | 18.58M | $160.23M | — |
表内 7 个季度中,机构持股合计减少 47%(Q1 2025 → Q3 2026);单季变动最大的是 Q2 2026(-33.7%)。
前 25 大机构持仓人(Q3 2026) — 12 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 4.40M | $40.56M | 0.66% | 增持 | |
| 2.49M | $26.93M | 0.82% | 减持 | |
| 851.99K | $9.27M | 0.18% | 增持 | |
| 786.46K | $8.56M | 0.42% | 持有 | |
| 581.79K | $6.33M | 0.33% | 持有 | |
| 374.87K | $4.08M | 0.81% | 新进 | |
| 115.61K | $1.25M | 0.51% | 持有 | |
| 60.38K | $656.96K | 0.00% | 减持 | |
| 51.48K | $556.45K | 0.00% | 增持 | |
| 36.40K | $393.12K | 0.01% | 持有 | |
| 4.62K | $49.95K | 0.00% | 新进 | |
| 392 | $4.23K | 0.00% | 新进 |
更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人
Q2 2026 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 2.51M | $26.71M | 0.77% | 减持 | |
| 2.07M | $21.93M | 0.35% | 增持 | |
| 1.15M | $12.20M | 0.24% | 减持 | |
| 999.90K | $10.65M | 0.32% | 减持 | |
| 832.09K | $8.86M | 0.18% | 减持 | |
| 809.05K | $8.62M | 0.35% | 减持 | |
| 786.46K | $8.38M | 0.49% | 减持 | |
| 648.08K | $6.90M | 1.59% | 持有 | |
| 581.79K | $6.20M | 0.31% | 减持 | |
| 350.00K | $3.73M | 0.06% | 减持 | |
| 162.79K | $1.73M | 0.05% | 持有 | |
| 382.44K | $1.65M | 0.01% | 增持 | |
| 115.61K | $1.23M | 0.59% | 新进 | |
| 109.96K | $1.17M | 0.25% | 新进 | |
| 100.00K | $1.06M | 0.00% | 减持 | |
| 97.84K | $1.04M | 0.09% | 减持 | |
| 65.55K | $698.12K | 0.11% | 减持 | |
| 62.27K | $663.21K | 0.00% | 新进 | |
| 62.27K | $663.21K | 0.00% | 持有 | |
| 49.89K | $531.34K | 0.00% | 持有 | |
| 50.00K | $503.00K | 0.09% | 新进 | |
| 36.40K | $387.66K | 0.01% | 持有 | |
| 31.84K | $339.10K | 0.07% | 持有 | |
| 18.48K | $196.00K | 0.00% | 减持 | |
| 28 | $298 | 0.00% | 减持 |
Q1 2026 — 25 家基金
Q4 2025 — 25 家基金
Q3 2025 — 25 家基金
Q2 2025 — 25 家基金
新建仓(Q2 2026)
- RLH Capital LLC 115.61K 股 · $1.23M
- Logan Stone Capital, LLC 109.96K 股 · $1.17M
- GEODE CAPITAL MANAGEMENT, LLC 62.27K 股 · $663.21K
- DELTEC ASSET MANAGEMENT LLC 50.00K 股 · $503.00K
完全清仓(较上季)
- D. E. Shaw & Co 卖出 690.00K 股 · $7.25M
- D. E. Shaw & Co., Inc. 卖出 690.00K 股 · $7.25M
- Shaolin Capital Management LLC 卖出 550.00K 股 · $5.76M
- Radcliffe Capital Management, L.P. 卖出 546.81K 股 · $5.74M
- LMR Partners LLP 卖出 500.00K 股 · $5.24M
- RIVERNORTH CAPITAL MANAGEMENT, LLC 卖出 418.00K 股 · $4.38M
- WHITEBOX ADVISORS LLC 卖出 400.00K 股 · $4.19M
- AQR Arbitrage LLC 卖出 357.58K 股 · $3.75M
- Hudson Bay Capital Management LP 卖出 297.83K 股 · $3.13M
- Context Capital Management, LLC 卖出 250.00K 股 · $2.62M
- Governors Lane LP 卖出 250.00K 股 · $2.62M
- L1 Global Manager Pty Ltd 卖出 200.00K 股 · $2.10M
基金持仓历史 — 各季度股数(前 20 只基金)
| 基金 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|
| MIZUHO SECURITIES USA LLC | 4.40M | 2.07M | 2.00M | 1.43M | 1.10M | 919.79K | — |
| Karpus Management, Inc. | 2.49M | 2.51M | 2.53M | 2.54M | 2.55M | 2.74M | 2.32M |
| WOLVERINE ASSET MANAGEMENT LLC | 851.99K | 832.09K | 1.55M | 1.31M | 1.25M | 1.02M | 603.04K |
| First Trust Capital Management L.P. | 786.46K | 786.46K | 2.24M | 2.24M | 2.24M | 2.24M | 2.07M |
| Westchester Capital Management, LLC | 581.79K | 581.79K | 1.67M | 1.67M | 1.67M | 1.67M | 979.00K |
| Crossingbridge Advisors, LLC | 374.87K | — | — | — | — | — | 850.00K |
| RLH Capital LLC | 115.61K | 115.61K | — | — | — | — | — |
| Geode Capital Management | 60.38K | 62.27K | 62.27K | 45.65K | 45.65K | 45.65K | 45.46K |
| JPMorgan Chase & Co | 51.48K | 49.89K | 49.88K | 49.82K | 99.69K | — | — |
| Dakota Wealth Management | 36.40K | 36.40K | 36.40K | 36.40K | 36.40K | — | — |
| Arax Advisory Partners | 4.62K | — | — | — | — | — | — |
| UBS Group AG | 392 | — | — | 38.16K | 20.12K | 1 | — |
| Polar Asset Management Partners Inc. | — | 1.15M | 1.60M | 1.60M | 1.90M | 1.90M | 1.90M |
| GLAZER CAPITAL, LLC | — | 999.90K | 1.68M | 1.82M | 1.82M | 1.82M | 1.82M |
| Hudson Bay Capital Management LP | — | — | 297.83K | 1.55M | 1.55M | 1.80M | 1.80M |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | — | 809.05K | 1.32M | — | — | — | — |
| ARISTEIA CAPITAL, L.L.C. | — | 350.00K | 881.72K | 881.72K | 881.72K | 881.72K | 900.00K |
| Mercuria Capital Strategies, LLC | — | — | — | 750.00K | — | — | — |
| D. E. Shaw & Co | — | — | 690.00K | 690.00K | 690.00K | 690.00K | — |
| D. E. Shaw & Co., Inc. | — | — | 690.00K | 690.00K | 690.00K | 690.00K | — |
▲ 低买(基金新建/增持,下一季股价上涨 ≥5%) ▼ 高卖(基金减持,下一季股价下跌 ≥5%)
拖拽/滚轮缩放 · 默认显示最近一年 · 标注来自 13F 申报中的季度基金操作 · 悬停查看详情
常见问题
Which funds hold DMAA?
As of 2026-Q2, 25 institutional funds reported holding DMAA (DRUGS MADE IN AMERICA ACQ CRP: 4/28/2026; CASH: $10.05) in SEC 13F filings, with a combined reported value of $126.04M.
How many shares of DMAA do institutions own?
13F filers reported 12.08M shares of DMAA, worth $126.04M in aggregate at the end of 2026-Q2.
Is institutional ownership of DMAA rising or falling?
Share counts moved -33.7% versus the prior quarter — distribution.
Who are the top institutional holders of DMAA?
The largest 13F holders are MIZUHO SECURITIES USA LLC, Karpus Management, Inc., Polar Asset Management Partners Inc., GLAZER CAPITAL, LLC, WOLVERINE ASSET MANAGEMENT LLC; the top 25 are ranked at the top of this page.
Who are the major shareholders of DRUGS MADE IN AMERICA ACQ CRP: 4/28/2026; CASH: $10.05?
The major shareholders of DRUGS MADE IN AMERICA ACQ CRP: 4/28/2026; CASH: $10.05 (DMAA) by reported 13F value are MIZUHO SECURITIES USA LLC, Karpus Management, Inc., Polar Asset Management Partners Inc., GLAZER CAPITAL, LLC, WOLVERINE ASSET MANAGEMENT LLC, among 54 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.